SOURCE: IOCircuit

April 11, 2006 07:15 ET

Cryobanks International (OTC: BTEM) Receives New Price Target of $9.25

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit.

LAKE HARMONY, PA -- (MARKET WIRE) -- April 11, 2006 -- The IO Circuit recommends Cryobanks International (OTC BB: BTEM), which announces that they have completed a full Spanish translation of the company's highly praised informational website. The website was initially launched in mid October 2005 and is considered a fundamental component in educating the Hispanic population and increasing minority cord blood donations.

Cryobanks International is currently a world leader in cord blood collection, processing, and banking. The company is the only bank in the United States who accepts cord blood donations from anywhere in the Continental United States.

For in-depth analyst coverage, go to http://www.smallcapstockalert.com

To read the complete release, go to http://www.cyberelease.com/btem41106.htm

Other active stocks are Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), Inhibitex, Inc. (NASDAQ: INHX) and OccuLogix, Inc. (NASDAQ: RHEO).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A Third Party has hired and paid $695.00 for the publication and circulation of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information